1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Cancer Drugs Market, by Type
6.1. Introduction
6.2. Bladder Cancer
6.3. Blood Cancer
6.4. Breast Cancer
6.5. Gastrointestinal Cancer
6.6. Liver Cancer
6.7. Lung and Bronchus Cancer
6.8. Skin Cancer

7. Cancer Drugs Market, by Application
7.1. Introduction
7.2. Chemotherapy
7.3. Hormone Therapy
7.4. Immunotherapy
7.5. Targeted Therapy

8. California Cancer Drugs Market

9. Florida Cancer Drugs Market

10. Illinois Cancer Drugs Market

11. New York Cancer Drugs Market

12. Ohio Cancer Drugs Market

13. Pennsylvania Cancer Drugs Market

14. Texas Cancer Drugs Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Amgen Inc.
16.2. Bayer AG
16.3. Boehringer Ingelheim International GmbH
16.4. Bristol-Myers Squibb Company
16.5. Celgene Corporation
16.6. Eli Lilly and Company
16.7. GlaxoSmithKline plc
16.8. Merck & Co., Inc.
16.9. Novartis AG
16.10. Pfizer Inc.
16.11. Sanofi

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES CANCER DRUGS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. UNITED STATES CANCER DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. UNITED STATES CANCER DRUGS MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES CANCER DRUGS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES CANCER DRUGS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CANCER DRUGS MARKET SIZE, BY TYPE, 2026
FIGURE 7. UNITED STATES CANCER DRUGS MARKET SIZE, BY BLADDER CANCER, 2018-2026 (USD BILLION)
FIGURE 8. UNITED STATES CANCER DRUGS MARKET SIZE, BY BLADDER CANCER, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 9. UNITED STATES CANCER DRUGS MARKET SIZE, BY BLOOD CANCER, 2018-2026 (USD BILLION)
FIGURE 10. UNITED STATES CANCER DRUGS MARKET SIZE, BY BLOOD CANCER, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 11. UNITED STATES CANCER DRUGS MARKET SIZE, BY BREAST CANCER, 2018-2026 (USD BILLION)
FIGURE 12. UNITED STATES CANCER DRUGS MARKET SIZE, BY BREAST CANCER, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 13. UNITED STATES CANCER DRUGS MARKET SIZE, BY GASTROINTESTINAL CANCER, 2018-2026 (USD BILLION)
FIGURE 14. UNITED STATES CANCER DRUGS MARKET SIZE, BY GASTROINTESTINAL CANCER, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 15. UNITED STATES CANCER DRUGS MARKET SIZE, BY LIVER CANCER, 2018-2026 (USD BILLION)
FIGURE 16. UNITED STATES CANCER DRUGS MARKET SIZE, BY LIVER CANCER, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 17. UNITED STATES CANCER DRUGS MARKET SIZE, BY LUNG AND BRONCHUS CANCER, 2018-2026 (USD BILLION)
FIGURE 18. UNITED STATES CANCER DRUGS MARKET SIZE, BY LUNG AND BRONCHUS CANCER, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 19. UNITED STATES CANCER DRUGS MARKET SIZE, BY SKIN CANCER, 2018-2026 (USD BILLION)
FIGURE 20. UNITED STATES CANCER DRUGS MARKET SIZE, BY SKIN CANCER, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 21. UNITED STATES CANCER DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 22. UNITED STATES CANCER DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CANCER DRUGS MARKET SIZE, BY APPLICATION, 2026
FIGURE 24. UNITED STATES CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, 2018-2026 (USD BILLION)
FIGURE 25. UNITED STATES CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 26. UNITED STATES CANCER DRUGS MARKET SIZE, BY HORMONE THERAPY, 2018-2026 (USD BILLION)
FIGURE 27. UNITED STATES CANCER DRUGS MARKET SIZE, BY HORMONE THERAPY, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 28. UNITED STATES CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, 2018-2026 (USD BILLION)
FIGURE 29. UNITED STATES CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 30. UNITED STATES CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, 2018-2026 (USD BILLION)
FIGURE 31. UNITED STATES CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, BY STATE, 2020 VS 2026 (USD BILLION)
FIGURE 32. UNITED STATES CANCER DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 33. UNITED STATES CANCER DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 34. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CANCER DRUGS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES CANCER DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CANCER DRUGS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. UNITED STATES CANCER DRUGS MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 5. UNITED STATES CANCER DRUGS MARKET SIZE, BY BLADDER CANCER, BY STATE, 2018-2026 (USD BILLION)
TABLE 6. UNITED STATES CANCER DRUGS MARKET SIZE, BY BLOOD CANCER, BY STATE, 2018-2026 (USD BILLION)
TABLE 7. UNITED STATES CANCER DRUGS MARKET SIZE, BY BREAST CANCER, BY STATE, 2018-2026 (USD BILLION)
TABLE 8. UNITED STATES CANCER DRUGS MARKET SIZE, BY GASTROINTESTINAL CANCER, BY STATE, 2018-2026 (USD BILLION)
TABLE 9. UNITED STATES CANCER DRUGS MARKET SIZE, BY LIVER CANCER, BY STATE, 2018-2026 (USD BILLION)
TABLE 10. UNITED STATES CANCER DRUGS MARKET SIZE, BY LUNG AND BRONCHUS CANCER, BY STATE, 2018-2026 (USD BILLION)
TABLE 11. UNITED STATES CANCER DRUGS MARKET SIZE, BY SKIN CANCER, BY STATE, 2018-2026 (USD BILLION)
TABLE 12. UNITED STATES CANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 13. UNITED STATES CANCER DRUGS MARKET SIZE, BY CHEMOTHERAPY, BY STATE, 2018-2026 (USD BILLION)
TABLE 14. UNITED STATES CANCER DRUGS MARKET SIZE, BY HORMONE THERAPY, BY STATE, 2018-2026 (USD BILLION)
TABLE 15. UNITED STATES CANCER DRUGS MARKET SIZE, BY IMMUNOTHERAPY, BY STATE, 2018-2026 (USD BILLION)
TABLE 16. UNITED STATES CANCER DRUGS MARKET SIZE, BY TARGETED THERAPY, BY STATE, 2018-2026 (USD BILLION)
TABLE 17. UNITED STATES CANCER DRUGS MARKET: SCORES
TABLE 18. UNITED STATES CANCER DRUGS MARKET: BUSINESS STRATEGY
TABLE 19. UNITED STATES CANCER DRUGS MARKET: PRODUCT SATISFACTION
TABLE 20. UNITED STATES CANCER DRUGS MARKET: RANKING
TABLE 21. UNITED STATES CANCER DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 22. UNITED STATES CANCER DRUGS MARKET: MERGER & ACQUISITION
TABLE 23. UNITED STATES CANCER DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 24. UNITED STATES CANCER DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 25. UNITED STATES CANCER DRUGS MARKET: INVESTMENT & FUNDING
TABLE 26. UNITED STATES CANCER DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 27. UNITED STATES CANCER DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

Amgen Inc.
Bayer AG
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Eli Lilly and Company
GlaxoSmithKline plc
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sanofi